Tumor Necrosis Factor-α Sensitizes Breast Cancer Cells to Natural Products with Proteasome-Inhibitory Activity Leading to Apoptosis

The inflammatory microenvironment plays an important role in the process of tumor development. Tumor necrosis factor-alpha (TNF-alpha), a key pro-inflammatory cytokine, has a significant role in this process. Natural medicinal products such as Withaferin A (WA) and Celastrol (Cel) have shown anti-cancer and anti-inflammatory properties that can be attributed to multiple mechanisms including, but not limited to, apoptosis induction due to the inhibition of proteasomal activities. This study aimed to investigate the effects of TNF-alpha in combination with WA or Cel in vitro in MDA-MB-231 breast cancer cells. TNF-alpha, when combined with WA or Cel, activated caspase-3 and -9 and downregulated XIAP in a dose-dependent manner, leading to induction of apoptosis in MDA-MB-231 breast cancer cells. The combination also caused accumulation of the proteasomal target protein I kappa B alpha, resulting in inhibition of the nuclear translocation of nuclear factor-kappa B (NF-kappa B). Taken together, these results suggest that TNF-alpha could sensitize breast cancer cells MDA-MB-231 to WA and Cel, at least in part, through inhibiting the activation of NF-kappa B signaling, leading to XIAP inhibition with subsequent upregulation of caspase-3 and -9 activities. Thus, the anti-cancer activities of TNF-alpha are enhanced when combined with the natural proteasome inhibitors, WA or Cel.